The Impact of C-Met Expression on the Immune Microenvironment and Survival in Locally Advanced Non-Small Cell Lung Cancer

被引：0
|
作者：
Xu, Xu. [1 ]
Xu, X. [1 ]
Zhu, Y. [1 ]
Ye, L. [2 ]
Zhang, Y. [1 ]
Zhang, W. [1 ]
Wu, L. [1 ]
Wu, C. [1 ]
Xu, Y. [1 ]
机构：
[1] Shanghai Pulm Hosp, Shanghai, Peoples R China
[2] Wenzhou Med Univ, Hangzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
Non-Small Cell Lung Cancer; Immune Microenvironment; cMET;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.08B.02
引用
收藏
页码：S566 / S566
页数：1
相关论文
共 50 条
  • [1] C-MET inhibitors for advanced non-small cell lung cancer
    Pasquini, Giulia
    Giaccone, Giuseppe
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (04) : 363 - 375
  • [2] Shedding of c-Met ectodomain correlates with c-Met expression in non-small cell lung cancer
    Fu, Le
    Guo, Wei
    Liu, Bingshan
    Sun, Linlin
    Bi, Zhenghong
    Zhu, Li
    Wang, Xinyan
    Liu, Bin
    Xie, Qian
    Li, Ke
    BIOMARKERS, 2013, 18 (02) : 126 - 135
  • [3] Expression of c-Met and HGF in non-small cell lung carcinomas
    I. V. Korobko
    M. V. Zinov’eva
    E. P. Kopantsev
    A. K. Allakhverdiev
    I. B. Zborovskaya
    E. D. Sverdlov
    Molecular Genetics, Microbiology and Virology, 2007, 22 (2) : 59 - 63
  • [4] Unveiling the Role of HGF/c-Met Signaling in Non-Small Cell Lung Cancer Tumor Microenvironment
    Yao, Shuxi
    Liu, Xinyue
    Feng, Yanqi
    Li, Yiming
    Xiao, Xiangtian
    Han, Yuelin
    Xia, Shu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [5] EGFR/c-Met and mTOR signaling are predictors of survival in non-small cell lung cancer
    Crees, Zachary D.
    Shearrow, Caleb
    Lin, Leo
    Girard, Jennifer
    Arasi, Kavin
    Bhoraskar, Aayush
    Berei, Joseph
    Eckburg, Adam
    Anderson, Austin D.
    Garcia, Christian
    Munger, Ariana
    Palani, Sunil
    Smith, Thomas J.
    Sreenivassappa, Shylendra B.
    Vitali, Connie
    David, Odile
    Puri, Neelu
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [6] Role of the HGF/c-MET pathway in resistance to immune checkpoint inhibitors in advanced non-small cell lung cancer
    Akli, Assya
    Kamga, Paul Takam
    Julie, Catherine
    Capron, Claude
    Costantini, Adrien
    Dumenil, Coraline
    Dumoulin, Jennifer
    Giraud, Violaine
    Parent, Florence
    Seferian, Andrei
    Guettier, Catherine
    Glorion, Mathieu
    Longchampt, Elisabeth
    Emile, Jean-Francois
    Giroux-Leprieur, Etienne
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (02)
  • [7] c-Met Amplification and Protein Expression in Non-Small Cell Lung Cancers
    Tsuta, K.
    Yoshida, A.
    Tsuda, H.
    LABORATORY INVESTIGATION, 2011, 91 : 426A - 426A
  • [8] Soluble c-Met Levels Correlated With Tissue c-Met Protein Expression in Patients With Advanced Non-Small-Cell Lung Cancer
    Gao, Hong-Fei
    Li, An-Na
    Yang, Jin-Ji
    Chen, Zhi-Hong
    Xie, Zhi
    Zhang, Xu-Chao
    Su, Jian
    Lou, Na-Na
    Yan, Hong-Hong
    Han, Jie-Fei
    Wu, Yi-Long
    CLINICAL LUNG CANCER, 2017, 18 (01) : 85 - 91
  • [9] Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?
    I. Watermann
    B. Schmitt
    F. Stellmacher
    J. Müller
    R. Gaber
    Ch. Kugler
    N. Reinmuth
    R. M. Huber
    M. Thomas
    P. Zabel
    K. F. Rabe
    D. Jonigk
    A. Warth
    E. Vollmer
    M. Reck
    T. Goldmann
    Diagnostic Pathology, 10
  • [10] Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?
    Watermann, I.
    Schmitt, B.
    Stellmacher, F.
    Mueller, J.
    Gaber, R.
    Kugler, Ch.
    Reinmuth, N.
    Huber, R. M.
    Thomas, M.
    Zabel, P.
    Rabe, K. F.
    Jonigk, D.
    Warth, A.
    Vollmer, E.
    Reck, M.
    Goldmann, T.
    DIAGNOSTIC PATHOLOGY, 2015, 10
12345